Michael Bosco, PharmD, BCIDP, AAHIVP(@theIDPharmD) 's Twitter Profileg
Michael Bosco, PharmD, BCIDP, AAHIVP

@theIDPharmD

Infectious Disease Clinical Pharmacist // Lover of bacteria, peanut butter, and cookies // All views are my own ๐Ÿณ๏ธโ€๐ŸŒˆ #stewardshipchronicles

ID:1219385446914019328

calendar_today20-01-2020 22:25:27

14,7K Tweets

64,9K Followers

764 Following

Michael Bosco, PharmD, BCIDP, AAHIVP(@theIDPharmD) 's Twitter Profile Photo

The important thing to remember is there is no human efficacy data re: the effectiveness of monkeypox vaccines.

Weโ€™re bound to see more breakthrough cases. We donโ€™t know what works or what provides optimal protection.

politico.eu/article/who-saโ€ฆ

account_circle
Michael Bosco, PharmD, BCIDP, AAHIVP(@theIDPharmD) 's Twitter Profile Photo

Treatment considerations (IV vs. PO):

Consider IV if:
- Swallowing difficulties
- Concern for impaired PO drug absorption (i.e. critically ill patients, gastric bypass, GI dysfunction)

account_circle
Michael Bosco, PharmD, BCIDP, AAHIVP(@theIDPharmD) 's Twitter Profile Photo

Treatment considerations (under E-IND):

Primary or early empiric treatment
- Confirmed non-variola orthopoxvirus infection
- Suspected infection

Secondary treatment (i.e. after needlestick injury) ยฑ vaccinia immune globulin

Post-exposure prophylaxis

account_circle